The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Apollo Therapeutics
Stock and Other Ownership Interests - Apollo Therapeutics
Efficacy of GCN2 inhibition by a novel small molecule AP030 in acute leukemia.
 
Nadine Clemo
Employment - Apollo Therapeutics
Stock and Other Ownership Interests - Apollo Therapeutics
Patents, Royalties, Other Intellectual Property - Apollo Therapeutics Ltd
 
Monica Roman-Trufero
Travel, Accommodations, Expenses - Apollo Therapeutics
 
Holger Auner
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Apollo Therapeutics
Patents, Royalties, Other Intellectual Property - Apollo Therapeutics Ltd
Travel, Accommodations, Expenses - Apollo Therapeutics; Roche
 
Richard Butt
No Relationships to Disclose
 
Armin Zebisch
Honoraria - Abbvie; Celgene; Novartis
Consulting or Advisory Role - Abbvie; Celgene/Jazz; Novartis
Research Funding - Apollo Therapeutics
Travel, Accommodations, Expenses - AstraZeneca
 
Panagiota Chaida
No Relationships to Disclose
 
Sereina Herzog
No Relationships to Disclose
 
Matthew Fuchter
Employment - NK:IO LTD
Leadership - Nk:IO LTD
Stock and Other Ownership Interests - Nk:IO
Consulting or Advisory Role - NK:IO Ltd
Patents, Royalties, Other Intellectual Property - Apollo Therapeutics Ltd; Nk:IO LTD